Supernus Pharmaceuticals: Pay

Supernus Pharmaceuticals paid its 5 named executives $21.6M in total in FY2025 (Dec). CEO Jack A. Khattar was paid $15.5M of that.

Pay$100 in the stock at the end of FY20 → $158
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Jack A. KhattarChief Executive Officer, President & Secretary
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Timothy C. DecSenior Vice President, Chief Financial Officer
FY2025 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
3 years
Jonathan Rubin, MDSenior Vice President, Chief Medical Officer Research and Development
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Padmanabh P. Bhatt, Ph.D.Senior Vice President, Intellectual Property, Chief Scientific Officer
FY2025 (Dec)
FY2023 (Dec)
FY2021 (Dec)Not disclosed
3 years
Frank MottolaSenior Vice President, Chief Technical Operations Officer
FY2025 (Dec)
FY2023 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $9.7M. The CEO of Supernus Pharmaceuticals was paid $15.5M, 60% above the median.

  1. 1PTC Therapeutics
  2. 2Supernus Pharmaceuticals
  3. 3Ultragenyx Pharmaceutical
  4. 4Alkermes plc.
  5. 5Harmony Biosciences Holdings
  6. 6Acadia PharmaceuticalsNot disclosed
  7. 7Ani PharmaceuticalsNot disclosed
  8. 8Amicus Therapeutics, Inc.Not disclosed
  9. 9Amphastar Pharmaceuticals, Inc.Not disclosed
  10. 10Axsome TherapeuticsNot disclosed
  11. 11Catalyst Pharmaceuticals, Inc.Not disclosed
  12. 12Collegium Pharmaceutical, Inc.Not disclosed
  13. 13Corcept TherapeuticsNot disclosed
  14. 14Dynavax Technologies CorporationNot disclosed
  15. 15Ligand PharmaceuticalsNot disclosed
  16. 16Pacira Biosciences, Inc.Not disclosed
  17. 17Xeris Biopharma Holdings, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.